These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 51795)

  • 1. Mechanism of action of rifamazine, a member of a new class of (dimeric) rifamycins.
    Fietta AM; Silvestri LG
    Eur J Biochem; 1975 Mar; 52(2):391-400. PubMed ID: 51795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of rifamycins with mammalian nucleic acid polymerizing enzymes.
    Sethi VS; Okano P
    Biochim Biophys Acta; 1976 Dec; 454(2):230-47. PubMed ID: 63293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A derivative of rifamycin SV inhibiting rifampicin-resistant RNA polymerase of Escherichia coli.
    Nikiforov VG; Trapkova AA; Gragerov AI; Maslin DN
    FEBS Lett; 1982 Dec; 150(2):416-8. PubMed ID: 6761147
    [No Abstract]   [Full Text] [Related]  

  • 4. Mu-induced rifamycin-resistant mutations not located in the rpoB gene of Escherichia coli.
    Kollenda MC; Kamp D; Hartmann GR
    Mol Gen Genet; 1986 Jul; 204(1):192-4. PubMed ID: 3528757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA blockade by rifampicin-inactivated Escherichia coli RNA polymerase, and its amelioration by a specific mutation.
    Hayward
    Eur J Biochem; 1976 Dec; 71(1):19-24. PubMed ID: 795662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of a rifamycin derivative (AF-013) which is active on the nucleic acid polymerases insensitive to rifampicin.
    Riva S; Fietta A; Silvestri LG
    Biochem Biophys Res Commun; 1972 Dec; 49(5):1263-71. PubMed ID: 4566674
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of rifampicin-resistant RNA synthesis by rifampicin-RNA polymerase complexes.
    Bordier C
    FEBS Lett; 1974 Sep; 45(1):259-62. PubMed ID: 4606670
    [No Abstract]   [Full Text] [Related]  

  • 8. R17 RNA replicase. V. Rifamycin sensitivity of R17 RNA synthesis in vivo.
    Igarashi SJ; Elliott FB
    J Biochem; 1975 Jun; 77(6):1261-9. PubMed ID: 773921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of Action of Kanglemycin A, an Ansamycin Natural Product that Is Active against Rifampicin-Resistant Mycobacterium tuberculosis.
    Mosaei H; Molodtsov V; Kepplinger B; Harbottle J; Moon CW; Jeeves RE; Ceccaroni L; Shin Y; Morton-Laing S; Marrs ECL; Wills C; Clegg W; Yuzenkova Y; Perry JD; Bacon J; Errington J; Allenby NEE; Hall MJ; Murakami KS; Zenkin N
    Mol Cell; 2018 Oct; 72(2):263-274.e5. PubMed ID: 30244835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical study of R-75-1, a new semi-synthetic rifamycin.
    Xiao-Chang F; Uehara Y; Abe Y; Hori M; Hamada M; Umezawa H
    J Antibiot (Tokyo); 1981 Jun; 34(6):713-8. PubMed ID: 6168632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of inhibition of RNA polymerase II and poly(adenylic acid) polymerase by the O-n-octyloxime of 3-formylrifamycin SV.
    Rose KM; Ruch PA; Jacob ST
    Biochemistry; 1975 Aug; 14(16):3598-604. PubMed ID: 1164499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of rifamycin derivatives on RNA polymerase of human leukemic lymphocytes.
    Tsai MJ; Saunders GF
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2072-6. PubMed ID: 4516206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modification of DNA-dependent RNA polymerase from Escherichia coli by an alkylating derivative of rifamycin SV.
    Stender W; Stütz AA; Scheit KH
    Eur J Biochem; 1975 Aug; 56(1):129-36. PubMed ID: 1100387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism of rifamycin inhibition and resistance in Pseudomonas aeruginosa.
    Yee YC; Kisslinger B; Yu VL; Jin DJ
    J Antimicrob Chemother; 1996 Jul; 38(1):133-7. PubMed ID: 8858465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGP 4832, a new semisynthetic rifamycin derivative highly active against some gram-negative bacteria.
    Wehrli W; Zimmermann W; Kump W; Tosch W; Vischer W; Zak O
    J Antibiot (Tokyo); 1987 Dec; 40(12):1733-9. PubMed ID: 2448280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin-resistant bacteriophage PBS2 infection and RNA polymerase in Bacillus subtilis.
    Price AR; Hitzeman R; Frato J; Lombardi K
    Nucleic Acids Res; 1974 Nov; 1(11):1497-502. PubMed ID: 10793705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of DNA synthesis by RNA.
    Zechel K
    Curr Top Microbiol Immunol; 1978; 82():71-112. PubMed ID: 83221
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Modification of DNA-dependent RNA polymerase.
    Zillig W; Fujiki H; Mailhammer R
    J Biochem; 1975 Jan; 77(1?):7p-8p. PubMed ID: 1094018
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of the topography of the binding site of DNA-dependent RNA polymerase from Escherichia coli for the antibiotic rifamycin SV.
    Stender W; Scheit KH
    Eur J Biochem; 1977 Jun; 76(2):591-600. PubMed ID: 330165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.